Press Releases

Filters
April 11, 2019

GenePOC obtains CE marked for its GenePOCTM Carba test

Read more
April 1, 2019

Debiopharm releases results of 3 key oncology compound programs at the 2019 American Association for Cancer Research (AACR) Conference in…

Read more
March 21, 2019

GenePOC obtains FDA clearance for its GenePOC™ Strep A test

Read more
March 12, 2019

ACTEON has entered into exclusive negotiations to acquire the Dental Division of VILLA SISTEMI MEDICALI

Read more
February 26, 2019

Debiopharm International SA Initiates a Clinical Trial Phase II study evaluating afabicin in Bone and Joint Infections

Read more
February 14, 2019

Debiopharm International SA Initiates FUZE, a Clinical Trial Phase II study evaluating Debio 1347 in Advanced Solid Tumors harboring an…

Read more
January 29, 2019

Challenge pour la Qualité de vie du patient 2019 : l’appel à projets est ouvert !

Read more
January 7, 2019

Debiopharm Group regains the commercial rights to Trelstar® (Triptorelin pamoate) and looks for new partners in North America

Read more
November 26, 2018

Grand succès du 3e Challenge pour la Qualité de vie des patients

Read more